PGF and Alzheimer disease: In the analysis of biomarkers across the AD continuum, placental growth factor (PGF) was significantly associated with disease stage, with an OR of 5.7 (95% CI:1.8–18, p = 0.002), indicating a 5.7‐fold increase in odds for more advanced stages per unit increase in PGF levels.